EGFR and colorectal carcinoma: One of the approaches to target a growth factor receptor is the inhibition of epidermal growth factor receptor (EGFR) by inhibiting EGFR tyrosine kinase using small-molecule inhibitors or antibody-induced receptor blockade in different human cancers, including colorectal cancer (CRC).